Literature DB >> 24715634

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors.

Andreas Dinkel1, Marielouise Kornmayer, Jürgen E Gschwend, Birgitt Marten-Mittag, Peter Herschbach, Kathleen Herkommer.   

Abstract

Familial clustering is common in prostate cancer (PCa), but the psychosocial consequences of being a PCa patient in an affected family are not well understood. This study investigated the effects of family history of PCa on psychosocial distress and perceived psychosocial treatment need. Data were gathered within the German national research project "Familial Prostate Cancer". 4.123 PCa survivors who had undergone prostatectomy at least 4 years ago received a questionnaire set. 3.623 of the respondents [68.3 % sporadic, sporadic prostate cancer (SPCa); 31.7 % familial, familial prosate cancer (FPCa)] filled in measures of cancer-specific distress (QSC-R10), depression (PHQ-2), and anxiety (GAD-2). Perceived psychosocial treatment need was assessed using a single item. The prevalence of psychosocial distress did not differ between SPCa and FPCa survivors (cancer-specific distress: 16.2 vs. 16.7 %; depression: 5.8 vs. 6.4 %; anxiety: 6.6 vs. 5.8 %; ps ≥ .397). Similarly, psychosocial treatment need did not differ between SPCa (11.8 %) and FPCa (13.1 %) cases (p = .303). However, family history moderated the effect of cancer-specific distress on treatment need (OR 2.67, 95 % CI 1.43-4.96, p = .002). Exploratory analyses for the hereditary subtype (HPCa) revealed that cancer-specific distress was lower in HPCa survivors who had only daughters compared to survivors without any children or with at least one son. No such effect was observed in SPCa survivors (p = .040). PCa survivors with a positive family history do not experience increased psychosocial distress. Nonetheless, family history may exert subtle effects that deserve further research.

Entities:  

Mesh:

Year:  2014        PMID: 24715634     DOI: 10.1007/s10689-014-9715-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  48 in total

Review 1.  A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.

Authors:  Stephen A Boorjian; James A Eastham; Markus Graefen; Bertrand Guillonneau; R Jeffrey Karnes; Judd W Moul; Edward M Schaeffer; Christian Stief; Kevin C Zorn
Journal:  Eur Urol       Date:  2011-12-07       Impact factor: 20.096

2.  Effect of personal cancer history and family cancer history on levels of psychological distress.

Authors:  Carolyn Rabin; Michelle L Rogers; Bernardine M Pinto; Justin M Nash; Georita M Frierson; Peter C Trask
Journal:  Soc Sci Med       Date:  2006-10-24       Impact factor: 4.634

3.  A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Authors:  Benjamin A Spencer; Susan H Babey; David A Etzioni; Ninez A Ponce; E Richard Brown; Hongjian Yu; Neetu Chawla; Mark S Litwin
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

4.  Familial risk and familial survival in prostate cancer.

Authors:  Kari Hemminki
Journal:  World J Urol       Date:  2011-11-25       Impact factor: 4.226

Review 5.  Hereditary prostate cancer: epidemiologic and clinical features.

Authors:  B S Carter; G S Bova; T H Beaty; G D Steinberg; B Childs; W B Isaacs; P C Walsh
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  [Ten years national research project "familial prostate cancer": problems in identifying risk families].

Authors:  K Herkommer; C Schmidt; J E Gschwend
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

Review 8.  Long-term oncological outcomes after laparoscopic radical prostatectomy.

Authors:  Marcel Hruza; Justo Lorenzo Bermejo; Bettina Flinspach; Michael Schulze; Dogu Teber; Hans Joachim Rumpelt; Jens Jochen Rassweiler
Journal:  BJU Int       Date:  2012-07-03       Impact factor: 5.588

9.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

10.  Worry about one's own children, psychological well-being, and interest in psychosocial intervention.

Authors:  Karin Stinesen-Kollberg; Thordis Thorsteinsdottir; Ulrica Wilderäng; Gunnar Steineck
Journal:  Psychooncology       Date:  2013-03-20       Impact factor: 3.894

View more
  4 in total

1.  Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.

Authors:  Valentin H Meissner; Kathleen Herkommer; Birgitt Marten-Mittag; Jürgen E Gschwend; Andreas Dinkel
Journal:  J Cancer Surviv       Date:  2017-05-21       Impact factor: 4.442

2.  Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population.

Authors:  Qun Wang; Hongchao Lv; Wenhua Lv; Miao Shi; Mingming Zhang; Meiwei Luan; Hongjie Zhu; Ruijie Zhang; Yongshuai Jiang
Journal:  Tumour Biol       Date:  2014-12-04

3.  Benefit finding in long-term prostate cancer survivors.

Authors:  Irène Lassmann; Andreas Dinkel; Birgitt Marten-Mittag; Matthias Jahnen; Helga Schulwitz; Jürgen E Gschwend; Kathleen Herkommer
Journal:  Support Care Cancer       Date:  2021-01-15       Impact factor: 3.359

4.  Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells.

Authors:  Kun Chen; Houqiang Xu; Jiafu Zhao
Journal:  Oxid Med Cell Longev       Date:  2019-05-09       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.